212 related articles for article (PubMed ID: 27060676)
1. How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.
Pastor CM
Contrast Media Mol Imaging; 2016 Jul; 11(4):291-8. PubMed ID: 27060676
[TBL] [Abstract][Full Text] [Related]
2. Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.
Daire JL; Leporq B; Vilgrain V; Van Beers BE; Schmidt S; Pastor CM
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):657-667. PubMed ID: 27778300
[TBL] [Abstract][Full Text] [Related]
3. Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.
Pastor CM
Contrast Media Mol Imaging; 2018; 2018():3839108. PubMed ID: 30116162
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of Gd-BOPTA in cholestatic fatty rat livers: role of transport functions through membrane proteins.
Pastor CM; Wissmeyer M; Millet P
Contrast Media Mol Imaging; 2013; 8(2):147-56. PubMed ID: 23281287
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
[TBL] [Abstract][Full Text] [Related]
6. New Pharmacokinetic Parameters of Imaging Substrates Quantified from Rat Liver Compartments.
Pastor CM; Brouwer KLR
Drug Metab Dispos; 2022 Jan; 50(1):58-64. PubMed ID: 34670777
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA.
Planchamp C; Pastor CM; Balant L; Becker CD; Terrier F; Gex-Fabry M
Invest Radiol; 2005 Nov; 40(11):705-14. PubMed ID: 16230903
[TBL] [Abstract][Full Text] [Related]
8. Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis of dynamic magnetic resonance images using a hollow-fiber bioreactor.
Planchamp C; Gex-Fabry M; Dornier C; Quadri R; Reist M; Ivancevic MK; Vallée JP; Pochon S; Terrier F; Balant L; Stieger B; Meier PJ; Pastor CM
Invest Radiol; 2004 Aug; 39(8):506-15. PubMed ID: 15257212
[TBL] [Abstract][Full Text] [Related]
9. Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.
Dahlqvist Leinhard O; Dahlström N; Kihlberg J; Sandström P; Brismar TB; Smedby O; Lundberg P
Eur Radiol; 2012 Mar; 22(3):642-53. PubMed ID: 21984449
[TBL] [Abstract][Full Text] [Related]
10. How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver.
Millet P; Moulin M; Stieger B; Daali Y; Pastor CM
J Pharmacol Exp Ther; 2011 Mar; 336(3):624-32. PubMed ID: 21131269
[TBL] [Abstract][Full Text] [Related]
11. Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats.
Pastor CM; Vilgrain V
Cells; 2021 Oct; 10(10):. PubMed ID: 34685713
[TBL] [Abstract][Full Text] [Related]
12. Chimeric mouse model for MRI contrast agent evaluation.
Mir FF; Tomaszewski RP; Shuboni-Mulligan DD; Mallett CL; Hix JML; Ether ND; Shapiro EM
Magn Reson Med; 2019 Jul; 82(1):387-394. PubMed ID: 30874333
[TBL] [Abstract][Full Text] [Related]
13. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers.
Planchamp C; Gex-Fabry M; Becker CD; Pastor CM
Invest Radiol; 2007 Jul; 42(7):513-21. PubMed ID: 17568274
[TBL] [Abstract][Full Text] [Related]
14. Application of Pharmacokinetic Modeling to Characterize Hepatobiliary Disposition of Imaging Agents and Alterations due to Liver Injury in Isolated Perfused Rat Livers.
Jeong A; Pastor CM; Brouwer KLR
Pharm Res; 2023 Nov; 40(11):2513-2523. PubMed ID: 37349653
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
16. Hollow fiber bioreactor: new development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging.
Planchamp C; Ivancevic MK; Pastor CM; Vallée JP; Pochon S; Terrier F; Mayer JM; Reist M
Biotechnol Bioeng; 2004 Mar; 85(6):656-65. PubMed ID: 14966807
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
18. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
Runge VM
J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.
Zhang T; Matsumura A; Yamamoto T; Yoshida F; Nose T; Shimojo N
AJNR Am J Neuroradiol; 2002 Jan; 23(1):15-8. PubMed ID: 11827870
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
